Loading…

Use of an NK1 Receptor Antagonist to Prevent Delayed Emesis After Cisplatin

Kris et al evaluated the NK1 receptor antagonist CP-122,721 in 17 cancer patients receiving cisplatin that induces acute vomiting in 98% of the patients not receiving antiemetics and delayed vomiting in 89%.

Saved in:
Bibliographic Details
Published in:JNCI : Journal of the National Cancer Institute 1997-06, Vol.89 (11), p.817-818
Main Authors: Kris, Mark G., Pizzo, Barbara A., Radford, James E., Inabinet, Robin, Hesketh, Ann, Hesketh, Paul J.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Kris et al evaluated the NK1 receptor antagonist CP-122,721 in 17 cancer patients receiving cisplatin that induces acute vomiting in 98% of the patients not receiving antiemetics and delayed vomiting in 89%.
ISSN:0027-8874
1460-2105
DOI:10.1093/jnci/89.11.817